These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9797492)
1. Clinical, biochemical and immunological characteristics of relapsers and non-relapsers of thyrotoxicosis treated with anti-thyroid drugs. Chowdhury TA; Dyer PH J Intern Med; 1998 Oct; 244(4):293-7. PubMed ID: 9797492 [TBL] [Abstract][Full Text] [Related]
2. Congenital thyrotoxicosis in premature infants. Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090 [TBL] [Abstract][Full Text] [Related]
3. Outcome of Graves' thyrotoxicosis after antithyroid drug treatment. Chiou SC; Houng HS; Li KL; Ghang TC; Lo SK; Sun RH; Huang YY; Hsu BR; Lin JD; Hunang BY Changgeng Yi Xue Za Zhi; 1995 Dec; 18(4):305-14. PubMed ID: 8851978 [TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism. De Leo S; Lee SY; Braverman LE Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492 [TBL] [Abstract][Full Text] [Related]
5. Thyrotropin receptor antibodies associated with post-operative relapse of thyrotoxicosis in a pregnancy complicated by neonatal thyrotoxicosis. Wilson R; Fraser WD; Gray CE; Alroomi LG; Thomson JA Scott Med J; 1990 Feb; 35(1):21-2. PubMed ID: 2315685 [TBL] [Abstract][Full Text] [Related]
6. Can thyroid stimulating hormone levels by TSH (IRMA) predict relapse of thyrotoxicosis following carbimazole treatment? Wilson R; Semple CG; Reid AM; Glen AC; McKillop JH; Thomson JA Postgrad Med J; 1987 Sep; 63(743):755-6. PubMed ID: 3444799 [TBL] [Abstract][Full Text] [Related]
7. Apathetic thyrotoxicosis. Cunningham C; Lyons D; O'Neill D Ir Med J; 1997; 90(4):155. PubMed ID: 9267098 [No Abstract] [Full Text] [Related]
8. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Maugendre D; Massart C Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931 [TBL] [Abstract][Full Text] [Related]
10. Logistic multiple regression analysis of factors predicting recurrence of hyperthyroidism after medical treatment of toxic diffuse goitre. de Rave S; Goldschmidt HM; Bravenboer B; Loosveld OJ; Lockefeer JH Neth J Med; 1991 Oct; 39(3-4):131-5. PubMed ID: 1791873 [TBL] [Abstract][Full Text] [Related]
11. High iodine (substrate) turnover Graves' disease: the intriguing 'rapid responder' variant of thyrotoxicosis. Dalan R; Leow MK; Ng DC Ann Clin Biochem; 2008 Nov; 45(Pt 6):612-5. PubMed ID: 18941129 [TBL] [Abstract][Full Text] [Related]
13. Thyrotoxicosis in patients with hypothyroidism is not just overtreatment. Kempegowda P; Nayak AU BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710200 [TBL] [Abstract][Full Text] [Related]
14. [Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture]. Henzen C; Buess M; Brander L Schweiz Med Wochenschr; 1999 May; 129(17):658-64. PubMed ID: 10407936 [TBL] [Abstract][Full Text] [Related]
16. Usage of a fixed dose of radioactive iodine for the treatment of hyperthyroidism: one-year outcome in a regional hospital in Hong Kong. Yau JS; Chu KS; Li JK; Chan KW; Lau IT; Yum SW; Chan CW; Mo LK; Kwan WK Hong Kong Med J; 2009 Aug; 15(4):267-73. PubMed ID: 19652233 [TBL] [Abstract][Full Text] [Related]